Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study-Reference-Cited by-同舟云学术

Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study

Published:2007-07 Issue:7 Volume:2 Page:S94-S100
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Onishi Hiroshi,Shirato Hiroki,Nagata Yasushi,Hiraoka Masahiro,Fujino Masaharu,Gomi Kotaro,Niibe Yuzuru,Karasawa Katsuyuki,Hayakawa Kazushige,Takai Yoshihiro,Kimura Tomoki,Takeda Atsuya,Ouchi Atsushi,Hareyama Masato,Kokubo Masaki,Hara Ryusuke,Itami Jun,Yamada Kazunari,Araki Tsutomu

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. American College of Chest Physicians: treatment of stage I non-small cell lung carcinoma;Smythe;Chest,2003

2. The role of radiotherapy in treatment of stage I non-small cell lung cancer;Qiao;Lung Cancer,2003

3. Computed tomography-guided frameless stereotactic radiography for stage I non-small-cell lung cancer: 5-year experience;Uematsu;Int J Radiat Oncol Biol Phys,2001

4. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame;Nagata;Int J Radiat Oncol Biol Phys,2005

5. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas;Fukumoto;Cancer,2002

Cited by 862 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally advanced pancreatic adenocarcinoma;Radiotherapy and Oncology;2024-11

2. New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights;The Journal of Liquid Biopsy;2024-09

3. Comparative analysis of delivered and planned doses in target volumes for lung stereotactic ablative radiotherapy;Radiation Oncology;2024-08-16

4. The effect of increasing the prescribed dose in stereotactic body radiotherapy for primary lung cancer without lymph node metastasis;Journal of Cancer Research and Therapeutics;2024-08-16

5. Performance of cone-beam computed tomography imaging during megavoltage beam irradiation under phase-gated conditions;Physica Medica;2024-07